NCT05628376View on ClinicalTrials.gov

TRAcking Thoracic Cancer Evolution Through Therapy (Rx) EVO

RecruitingOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

December 4, 2023

Primary Completion Date

December 31, 2030

Study Completion Date

June 30, 2034

Conditions
Lung Cancer, Non-small CellSmall Cell Lung CancerPleural Mesothelioma
Trial Locations (1)

NW1 2PG

RECRUITING

University College London Hospitals NHS Foundation Trust, London

Sponsors

Collaborators (1)

Cancer Research UK
All Listed Sponsors
collaborator

Cancer Research UK

OTHER

lead

University College, London

OTHER

NCT05628376 - TRAcking Thoracic Cancer Evolution Through Therapy (Rx) EVO | Biotech Hunter | Biotech Hunter